Log in to search using one of your social media accounts:

 

New structure of key protein holds clues for better drug design

Scientists at The Scripps Research Institute (TSRI) have peered deep into the heart of a key protein used in drug design and discovered dynamic structural features that may lead to new ways to target diseases. The protein, called the A2A adenosine receptor (A2aAR), is a member of the G-protein-coupled receptor (GPCR) family, which are the targets of roughly 40 percent of all approved pharmaceuticals.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Related Links:

Source: Current Problems in Cardiology - Category: Cardiology Source Type: research
Source: Current Problems in Cardiology - Category: Cardiology Source Type: research
Source: Current Problems in Cardiology - Category: Cardiology Source Type: research
Source: Current Problems in Cardiology - Category: Cardiology Source Type: research
Source: Current Problems in Cardiology - Category: Cardiology Source Type: research
Source: Current Problems in Cardiology - Category: Cardiology Source Type: research
Source: Cardiovascular and Haematological Disorders - Drug Targets - Category: Cardiology Authors: Tags: Articles Source Type: research
Source: Cardiovascular and Haematological Disorders - Drug Targets - Category: Cardiology Authors: Tags: Review article Source Type: research
Source: Cardiovascular and Haematological Disorders - Drug Targets - Category: Cardiology Authors: Tags: Review article Source Type: research
Source: Cardiovascular and Haematological Disorders - Drug Targets - Category: Cardiology Authors: Tags: Review article Source Type: research
More News: Cardiology | Heart | Pharmaceuticals